Current diagnostic and quantitative techniques in the field of lymphedema management: a critical review.

Cancer Diagnosis Imaging Lymphedema Measurement Monitoring Screening

Journal

Medical oncology (Northwood, London, England)
ISSN: 1559-131X
Titre abrégé: Med Oncol
Pays: United States
ID NLM: 9435512

Informations de publication

Date de publication:
05 Sep 2024
Historique:
received: 31 05 2024
accepted: 02 08 2024
medline: 5 9 2024
pubmed: 5 9 2024
entrez: 5 9 2024
Statut: epublish

Résumé

Lymphedema evaluation entails multifaceted considerations for which options continue to evolve and emerge. This paper provides a critical review of the current status of diagnostic and quantitative measures for lymphedema, from traditional and novel bedside assessment tools for volumetric and fluid assessment, to advanced imaging modalities. Modalities are contrasted with regard to empirical support and feasibility of clinical implementation. The manuscript proposes a grid framework for comparing the ability of each modality to quantify specific lymphedema characteristics, including distribution, dysmorphism, tissue composition and fluid content, lymphatic anatomy and function, metaplasia, clinical symptoms, and quality of life and function. This review additionally applies a similar framework approach to consider how well assessment tools support important clinical needs, including: (1) screening, (2) diagnosis and differential diagnosis, (3) individualization of treatment, and (4) monitoring treatment response. The framework highlights which clinical needs are served by an abundance of assessment tools and identifies others that have problematically few. The framework clarifies which tools have greater or lesser empirical support. The framework is designed to assist stakeholders in selecting appropriate diagnostic and surveillance modalities, gauging levels of confidence when applying tools to specific clinical needs, elucidating overarching patterns of diagnostic and quantitative strengths and weaknesses, and informing future investigation.

Identifiants

pubmed: 39235664
doi: 10.1007/s12032-024-02472-9
pii: 10.1007/s12032-024-02472-9
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

241

Informations de copyright

© 2024. Crown.

Références

O’Donnell TF Jr, Rasmussen JC, Sevick-Muraca EM. New diagnostic modalities in the evaluation of lymphedema. J Vasc Surg Venous Lymphat Disord. 2017;5(2):261–73. https://doi.org/10.1016/j.jvsv.2016.10.083 .
doi: 10.1016/j.jvsv.2016.10.083 pubmed: 28214496 pmcid: 5325714
Levenhagen K, Davies C, Perdomo M, Ryans K, Gilchrist L. Diagnosis of upper quadrant lymphedema secondary to cancer: clinical practice guideline from the oncology section of the American physical therapy association. Phys Ther. 2017;97(7):729–45. https://doi.org/10.1093/ptj/pzx050 .
doi: 10.1093/ptj/pzx050 pubmed: 28838217 pmcid: 5803775
O’Donnell TF Jr, Allison GM, Iafrati MD. A systematic review of guidelines for lymphedema and the need for contemporary intersocietal guidelines for the management of lymphedema. J Vasc Surg Venous Lymphat Disord. 2020;8(4):676–84. https://doi.org/10.1016/j.jvsv.2020.03.006 .
doi: 10.1016/j.jvsv.2020.03.006 pubmed: 32444277
Lurie F, Malgor RD, Carman T, Dean SM, Iafrati MD, Khilnani NM, Labropoulos N, Maldonado TS, Mortimer P, O’Donnell TF Jr, Raffetto JD, Rockson SG, Gasparis AP. The American venous forum, American vein and lymphatic society and the society for vascular medicine expert opinion consensus on lymphedema diagnosis and treatment. Phlebology. 2022;37(4):252–66. https://doi.org/10.1177/02683555211053532 .
doi: 10.1177/02683555211053532 pubmed: 35258350 pmcid: 9069652
Executive Committee of the International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2020 consensus document of the international society of lymphology. Lymphology. 2020;53(1):3–19.
Stubblefield MD, Weycker D. Under recognition and treatment of lymphedema in head and neck cancer survivors—a database study. Support Care Cancer. 2023;31:229. https://doi.org/10.1007/s00520-023-07698-3 .
doi: 10.1007/s00520-023-07698-3 pubmed: 36952136 pmcid: 10188415
Russo S, Walker JL, Carlson JW, Carter J, Ward LC, Covens A, Tanner EJ 3rd, Armer JM, Ridner S, Hayes S, Taghian AG, Brunelle C, Lopez-Acevedo M, Davidson BA, Schaverien MV, Ghamande SA, Bernas M, Cheville AL, Yost KJ, Schmitz K, Coyle B, Zucker J, Enserro D, Pugh S, Paskett ED, Ford L, McCaskill-Stevens W. Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers. Gynecol Oncol. 2021;160(2):625–32. https://doi.org/10.1016/j.ygyno.2020.10.026 .
doi: 10.1016/j.ygyno.2020.10.026 pubmed: 33158510
Havens LM, Brunelle CL, Gillespie TC, Bernstein M, Bucci LK, Kassamani YW, Taghian AG. Use of technology to facilitate a prospective surveillance program for breast cancer-related lymphedema at the Massachusetts general hospital. Mhealth. 2021;7:11. https://doi.org/10.21037/mhealth-19-218.PMID:33634194;PMCID:PMC7882272 .
doi: 10.21037/mhealth-19-218.PMID:33634194;PMCID:PMC7882272 pubmed: 33634194 pmcid: 7882272
Sun F, Skolny MN, Swaroop MN, Rawal B, Catalano PJ, Brunelle CL, Miller CL, Taghian AG. The need for preoperative baseline arm measurement to accurately quantify breast cancer-related lymphedema. Breast Cancer Res Treat. 2016;157(2):229–40. https://doi.org/10.1007/s10549-016-3821- .
doi: 10.1007/s10549-016-3821- pubmed: 27154787
Armer JM, Hulett JM, Bernas M, Ostby P, Stewart BR, Cormier JN. Best practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema. Curr Breast Cancer Rep. 2013;5(2):134–44. https://doi.org/10.1007/s12609-013-0105-0 .
doi: 10.1007/s12609-013-0105-0 pubmed: 26246870 pmcid: 4523280
Kassamani YW, Brunelle CL, Gillespie TC, Bernstein MC, Bucci LK, Nassif T, Taghian AG. Diagnostic criteria for breast cancer-related lymphedema of the upper extremity: the need for universal agreement. Ann Surg Oncol. 2022;29(2):989–1002. https://doi.org/10.1245/s10434-021-10645-3 .
doi: 10.1245/s10434-021-10645-3 pubmed: 34505218
Brunelle CL, Taghian AG. ASO author reflections: breast cancer-related lymphedema-a suggested clinical pathway for diagnosis. Ann Surg Oncol. 2022;29(2):1003–4. https://doi.org/10.1245/s10434-021-10702-x .
doi: 10.1245/s10434-021-10702-x pubmed: 34499258
Pappalardo M, Starnoni M, Franceschini G, Baccarani A, De Santis G. Breast cancer-related lymphedema: recent updates on diagnosis, severity and available treatments. J Pers Med. 2021;11(5):402. https://doi.org/10.3390/jpm11050402 .
doi: 10.3390/jpm11050402 pubmed: 34065795 pmcid: 8151072
Farrow W. Phlebolymphedema-a common underdiagnosed and undertreated problem in the wound care clinic. J Am Col Certif Wound Spec. 2010;2(1):14–23. https://doi.org/10.1016/j.jcws.2010.04.004 .
doi: 10.1016/j.jcws.2010.04.004 pubmed: 24527138 pmcid: 3601853
Sleigh BC, Manna B. Lymphedema. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537239/ . Accessed 6 Mar 2023.
Fife CE, Farrow W, Hebert AA, Armer NC, Stewart BR, Cormier JN, Armer JM. Skin and wound care in lymphedema patients: a taxonomy, primer, and literature review. Adv Skin Wound Care. 2017;30(7):305–18. https://doi.org/10.1097/01.ASW.0000520501.23702.82 .
doi: 10.1097/01.ASW.0000520501.23702.82 pubmed: 28617750
Johnson KC, Kennedy AG, Henry SM. Clinical measurements of lymphedema. Lymphat Res Biol. 2014;12(4):216–21. https://doi.org/10.1089/lrb.2014.0019 .
doi: 10.1089/lrb.2014.0019 pubmed: 25317946
Greene AK, Goss JA. Diagnosis and staging of lymphedema. Semin Plast Surg. 2018;32(1):12–6. https://doi.org/10.1055/s-0038-1635117 .
doi: 10.1055/s-0038-1635117 pubmed: 29636648 pmcid: 5891654
Cheville AL, McGarvey CL, Petrek JA, Russo SA, Thiadens SR, Taylor ME. The grading of lymphedema in oncology clinical trials. Semin Radiat Oncol. 2003;13(3):214–25. https://doi.org/10.1016/S1053-4296(03)00038-9 .
doi: 10.1016/S1053-4296(03)00038-9 pubmed: 12903011
Campisi C, Davini D, Bellini C, Taddei G, Villa G, Fulcheri E, Zilli A, Da Rin E, Eretta C, Boccardo F. Lymphatic microsurgery for the treatment of lymphedema. Microsurgery. 2006;26:65–9.
pubmed: 16444753 doi: 10.1002/micr.20214
CTCAE 5.0. https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf . Accessed 10 May 2024.
CTCAE 3.0. https://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf . Accessed 10 May 2024.
Sanderson J, Tuttle N, Box R, Reul-Hirche HM, Laakso EL. The pitting test; an investigation of an unstandardized assessment of lymphedema. Lymphology. 2015;48(4):175–83.
pubmed: 27164763
Sayegh HE, Asdourian MS, Swaroop MN, Brunelle CL, Skolny MN, Salama L, Taghian AG. Diagnostic methods, risk factors, prevention, and management of breast cancer-related lymphedema: past, present, and future directions. Curr Breast Cancer Rep. 2017;9(2):111–21. https://doi.org/10.1007/s12609-017-0237-8 .
doi: 10.1007/s12609-017-0237-8 pubmed: 28894513 pmcid: 5590641
McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008;26:5213–9.
pubmed: 18838709 pmcid: 2652091 doi: 10.1200/JCO.2008.16.3725
Ancukiewicz M, Miller CL, Skolny MN, O’Toole J, Warren LE, Jammallo LS, Specht MC, Taghian AG. Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology. Breast Cancer Res Treat. 2012;135(1):145–52. https://doi.org/10.1007/s10549-012-2111-8 .
doi: 10.1007/s10549-012-2111-8 pubmed: 22710706 pmcid: 3564235
Hidding JT, Viehoff PB, Beurskens CH, van Laarhoven HW, Nijhuis-van der Sanden MW, van der Wees PJ. Measurement properties of instruments for measuring of lymphedema: systematic review. Phys Ther. 2016;96(12):1965–81. https://doi.org/10.2522/ptj.20150412 .
doi: 10.2522/ptj.20150412 pubmed: 27340195
Dixon JB, Weiler MJ. Bridging the divide between pathogenesis and detection in lymphedema. Semin Cell Dev Biol. 2015;38:75–82. https://doi.org/10.1016/j.semcdb.2014.12.003 .
doi: 10.1016/j.semcdb.2014.12.003 pubmed: 25545813
Tandra P, Kallam A, Krishnamurthy J. Identification and management of lymphedema in patients with breast cancer. J Oncol Pract. 2019;15(5):255–62. https://doi.org/10.1200/JOP.18.00141 .
doi: 10.1200/JOP.18.00141 pubmed: 31009281
Taylor R, Jayasinghe UW, Koelmeyer L, Ung O, Boyages J. Reliability and validity of arm volume measurements for assessment of lymphedema. Phys Ther. 2006;86:205–14.
pubmed: 16445334 doi: 10.1093/ptj/86.2.205
Sander AP, Hajer NM, Hemenway K, Miller AC. Upper-extremity volume measurements in women with lymphedema: a comparison of measurements obtained via water displacement with geometrically determined volume. Phys Ther. 2002;82(12):1201–12.
pubmed: 12444879 doi: 10.1093/ptj/82.12.1201
Miller CL, Specht MC, Horick N, Skolny MN, Jammallo LS, O’Toole J, Taghian AG. A novel, validated method to quantify breast cancer-related lymphedema (BCRL) following bilateral breast surgery. Lymphology. 2013;46(2):64–74.
pubmed: 24354105
Sun F, Hall A, Tighe MP, Brunelle CL, Sayegh HE, Gillespie TC, Daniell KM, Taghian AG. Perometry versus simulated circumferential tape measurement for the detection of breast cancer-related lymphedema. Breast Cancer Res Treat. 2018;172(1):83–91. https://doi.org/10.1007/s10549-018-4902-z .
doi: 10.1007/s10549-018-4902-z pubmed: 30062571 pmcid: 6191334
Megens AM, Harris SR, Kim-Sing C, McKenzie DC. Measurement of upper extremity volume in women after axillary dissection for breast cancer. Arch Phys Med Rehabil. 2001;82:1639–44.
pubmed: 11733875 doi: 10.1053/apmr.2001.26822
Perdomo M, Levenhagen K, Davies C, Ryans K. Assessment measures of secondary lymphedema in breast cancer survivors. Rehabil Oncol. 2014;32(1):22–35.
doi: 10.1097/01893697-201432010-00005
Sharkey AR, King SW, Kuo RY, Bickerton SB, Ramsden AJ, Furniss D. Measuring limb volume: accuracy and reliability of tape measurement versus perometer measurement. Lymphat Res Biol. 2018;16(2):182–6. https://doi.org/10.1089/lrb.2017.0039 .
doi: 10.1089/lrb.2017.0039 pubmed: 28956715
Armer JM. The problem of post-breast cancer lymphedema: impact and measurement issues. Cancer Invest. 2005;23(1):76–83.
pubmed: 15779870 doi: 10.1081/CNV-48707
Lee MJ, Boland RA, Czerniec S, Kilbreath SL. Reliability and concurrent validity of the perometer for measuring hand volume in women with and without lymphedema. Lymphat Res Biol. 2011;9(1):13–8. https://doi.org/10.1089/lrb.2010.0021 .
doi: 10.1089/lrb.2010.0021 pubmed: 21417763
Thomas B, Cornish BH, Ward LC. Bioelectrical impedance analysis for measurement of body fluid volumes a review. J Clin Eng. 1992;17:505–10.
pubmed: 10124463 doi: 10.1097/00004669-199211000-00016
York SL, Ward LC, Czerniec S, Lee MJ, Refshauge KM, Kilbreath SL. Single frequency versus bioimpedance spectroscopy for the assessment of lymphedema. Breast Cancer Res Treat. 2009;117(1):177–82.
pubmed: 18563555 doi: 10.1007/s10549-008-0090-6
Ward LC. Inter-instrument comparison of bioimpedance spectroscopic analysers. Open Med Device J. 2009;1:3–10.
doi: 10.2174/1875181400901010003
Cornish B. Bioimpedance analysis: scientific background. Lymphat Res Biol. 2006;4(1):47–50.
pubmed: 16569208 doi: 10.1089/lrb.2006.4.47
Price KL, Earthman CP. Update on body composition tools in clinical settings: computed tomography, ultrasound, and bioimpedance applications for assessment and monitoring. Eur J Clin Nutr. 2019;73:187–93. https://doi.org/10.1038/s41430-018-0360-2 .
doi: 10.1038/s41430-018-0360-2 pubmed: 30377307
Hui D, Dev R, Pimental L, Park M, Cerana MA, Liu D, Bruera E. Association between multi-frequency phase angle and survival in patients with advanced cancer. J Pain Symptom Manage. 2017;53(3):571–7. https://doi.org/10.1016/j.jpainsymman.2016.09.016 .
doi: 10.1016/j.jpainsymman.2016.09.016 pubmed: 28042079
Ward LC. Bioelectrical impedance spectrometry for the assessment of lymphoedema: principles and practice. In: Greene AK, Slavin SA, Brorson H, editors. Lymphedema. Switzerland: Springer International Publishing; 2015. p. 123–32.
doi: 10.1007/978-3-319-14493-1_12
Fu MR, Cleland CM, Guth AA, Kayal M, Haber J, Cartwright F, Kleinman R, Kang Y, Scagliola J, Axelrod D. L-dex ratio in detecting breast cancer-related lymphedema: reliability, sensitivity, and specificity. Lymphology. 2013;46(2):85–96.
pubmed: 24354107 pmcid: 4040962
Soran A, Ozmen T, McGuire KP, Diego EJ, McAuliffe PF, Bonaventura M, Ahrendt GM, DeGore L, Johnson R. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study. Lymphat Res Biol. 2014;12(4):289–94.
pubmed: 25495384 doi: 10.1089/lrb.2014.0035
Dylke ES, Schembri GP, Bailey DL, Bailey E, Ward LC, Refshauge K, Beith J, Black D, Kilbreath SL. Diagnosis of upper limb lymphedema: development of an evidence-based approach. Acta Oncol. 2016;55:1477–83. https://doi.org/10.1080/0284186X.2016.1191668 .
doi: 10.1080/0284186X.2016.1191668 pubmed: 27333213
Kilbreath SL, Refshauge KM, Beith JM, Ward LC, Ung OA, Dylke ES, French JR, Yee J, Koelmeyer L, Gaitatzis K. Risk factors for lymphoedema in women with breast cancer: a large prospective cohort. Breast. 2016;28:29–36.
pubmed: 27183497 doi: 10.1016/j.breast.2016.04.011
Tattersall J. Bioimpedance analysis in dialysis: state of the art and what we can expect. Blood Purif. 2009;27(1):70–4.
pubmed: 19169021 doi: 10.1159/000167012
Sullivan PA, Still CD, Jamieson ST, Dixon CB, Irving BA, Andreacci JL. Evaluation of multi-frequency bioelectrical impedance analysis for the assessment of body composition in individuals with obesity. Obes Sci Pract. 2019;5(2):141–7.
pubmed: 31019731 doi: 10.1002/osp4.321
Mayrovitz HN, Weingrad DN, Davey S. Tissue dielectric constant (TDC) measurements as a means of characterizing localized tissue water in arms of women with and without breast cancer treatment related lymphedema. Lymphology. 2014;47(3):142–50.
pubmed: 25420307
Jane Wigg J, Pugh S, Phillips N. The use of tissue dielectric constant in the assessment of lymphoedema. British Journal of Community Nursing, LTA: Compendium of best practice. 2023; S14-S8.
Mayrovitz HN, Somarriba C, Weingrad DN. Breast tissue dielectric constant as a potential breast edema assessment parameter. Lymphat Res Biol. 2022;20(1):33–8. https://doi.org/10.1089/lrb.2020.0137 .
doi: 10.1089/lrb.2020.0137 pubmed: 33761280
Mayrovitz HN. Tissue dielectric constant of the lower leg as an index of skin water: temporal variations. Cureus. 2022;14(7):e26506. https://doi.org/10.7759/cureus.26506.PMID:35923478;PMCID:PMC9339369 .
doi: 10.7759/cureus.26506.PMID:35923478;PMCID:PMC9339369 pubmed: 35923478 pmcid: 9339369
Mayrovitz HN, Weingrad DN, Lopez L. Assessing localized skin-to-fat water in arms of women with breast cancer via tissue dielectric constant measurements in pre- and post-surgery patients. Ann Surg Oncol. 2015;22(5):1483–9. https://doi.org/10.1245/s10434-014-4185-5 .
doi: 10.1245/s10434-014-4185-5 pubmed: 25388057
Mazor M, Smoot BJ, Mastick J, Mausisa G, Paul SM, Kober KM, Elboim C, Singh K, Conley YP, Mickevicius G, Field J, Hutchison H, Miaskowski C. Assessment of local tissue water in the arms and trunk of breast cancer survivors with and without upper extremity lymphoedema. Clin Physiol Funct Imaging. 2019;39(1):57–64. https://doi.org/10.1111/cpf.12541 .
doi: 10.1111/cpf.12541 pubmed: 30207039
Chen Y-W, Tsai H-J, Hung H-C, Tsauo J-Y. Reliability study of measurements for lymphedema in breast cancer patients. Am J Phys Med Rehabil. 2008;87(1):33–8.
pubmed: 17993983 doi: 10.1097/PHM.0b013e31815b6199
Moseley A, Piller N. Reliability of bioimpedance spectroscopy and tonometry after breast conserving cancer treatment. Lymphat Res Biol. 2008;6:85–7.
pubmed: 18564923 doi: 10.1089/lrb.2008.1002
Piller N, Keeley V, Ryan TJ, Hayes S, Ridner S. Early detection—a strategy to reduce risk and severity? J Lymphoedema. 2009;4:89–95.
Liu NF, Olszewski W. Use of tonometry to assess lower extremity lymphedema. Lymphology. 1992;25:155–8.
pubmed: 1293430
Kar SK, Kar PK, Mania J. Tissue tonometry: a useful tool for assessing filarial lymphedema. Lymphology. 1992;25:55–61.
pubmed: 1405748
Binkley JM, Weiler MJ, Frank N, Bober L, Dixon JB, Stratford PW. Assessing arm volume in people during and after treatment for breast cancer: reliability and convergent validity of the LymphaTech System. Phys Ther. 2020;100:457–67. https://doi.org/10.1093/ptj/pzz175 .
doi: 10.1093/ptj/pzz175 pubmed: 32043125
Rumbo-Rodríguez L, Sánchez-SanSegundo M, Ferrer-Cascales R, García-D’Urso N, Hurtado-Sánchez JA, Zaragoza-Martí A. Comparison of body scanner and manual anthropometric measurements of body shape: a systematic review. Int J Environ Res Public Health. 2021;18:6213.
pubmed: 34201258 pmcid: 8230172 doi: 10.3390/ijerph18126213
Beelen LM, van Dishoeck AM, Tsangaris E, et al. Patient-reported outcome measures in lymphedema: a systematic review and COSMIN analysis. Ann Surg Oncol. 2021;28(3):1656–68. https://doi.org/10.1245/s10434-020-09346-0 .
doi: 10.1245/s10434-020-09346-0 pubmed: 33249519
Eidenberger M. Patient-reported outcome measures with secondary lower limb lymphedemas: a systematic review. J Adv Pract Oncol. 2021;12(2):174–87. https://doi.org/10.6004/jadpro.2021.12.2.5 .
doi: 10.6004/jadpro.2021.12.2.5 pubmed: 34109049 pmcid: 8017801
Pusic AL, Cemal Y, Albornoz C, et al. Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes. J Cancer Surviv. 2013;7(1):83–92. https://doi.org/10.1007/s11764-012-0247-5 .
doi: 10.1007/s11764-012-0247-5 pubmed: 23212603
Cemal Y, Jewell S, Albornoz CR, Pusic A, Mehrara BJ. Systematic review of quality of life and patient reported outcomes in patients with oncologic related lower extremity lymphedema. Lymphat Res Biol. 2013;11(1):14–9. https://doi.org/10.1089/lrb.2012.0015 .
doi: 10.1089/lrb.2012.0015 pubmed: 23531180 pmcid: 3654818
Russo S, Walker JL, Carlson JW, et al. Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers. Gynecol Oncol. 2021;160(2):625–32. https://doi.org/10.1016/j.ygyno.2020.10.026 .
doi: 10.1016/j.ygyno.2020.10.026 pubmed: 33158510
Coriddi M, Dayan J, Sobti N, et al. Systematic review of patient-reported outcomes following surgical treatment of lymphedema. Cancers (Basel). 2020. https://doi.org/10.3390/cancers12030565 .
doi: 10.3390/cancers12030565 pubmed: 32121343
Klassen AF, Tsangaris E, Kaur MN, et al. Development and psychometric validation of a patient-reported outcome measure for arm lymphedema: the LYMPH-Q upper extremity module. Ann Surg Oncol. 2021;28(9):5166–82. https://doi.org/10.1245/s10434-021-09887-y .
doi: 10.1245/s10434-021-09887-y pubmed: 34224044 pmcid: 8349351
Williams AE, Rapport F, Russell IT, Hutchings HA. Psychometric development of the upper limb lymphedema quality of life questionnaire demonstrated the patient-reported outcome measure to be a robust measure for breast cancer-related lymphedema. J Clin Epidemiol. 2018;100:61–70. https://doi.org/10.1016/j.jclinepi.2018.04.014 .
doi: 10.1016/j.jclinepi.2018.04.014 pubmed: 29723583
Yost KJ, Cheville AL, Weaver AL, Al Hilli M, Dowdy SC. Development and validation of a self-report lower-extremity lymphedema screening questionnaire in women. Phys Ther. 2013;93(5):694–703. https://doi.org/10.2522/ptj.20120088 .
doi: 10.2522/ptj.20120088 pubmed: 23288911
Armer JM, Radina ME, Porock D, Culbertson SD. Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res. 2003;52(6):370–9. https://doi.org/10.1097/00006199-200311000-00004 .
doi: 10.1097/00006199-200311000-00004 pubmed: 14639083
Armer JM, Stewart BR. A comparison of four diagnostic criteria for lymphedema in a post-breast cancer population. Lymphat Res Biol. 2005;3(4):208–17. https://doi.org/10.1089/lrb.2005.3.208 .
doi: 10.1089/lrb.2005.3.208 pubmed: 16379589
Norman SA, Miller LT, Erikson HB, Norman MF, McCorkle R. Development and validation of a telephone questionnaire to characterize lymphedema in women treated for breast cancer. Phys Ther. 2001;81(6):1192–205.
pubmed: 11380275 doi: 10.1093/ptj/81.6.1192
Carter J, Raviv L, Appollo K, Baser RE, Iasonos A, Barakat RR. A pilot study using the gynecologic cancer lymphedema questionnaire (GCLQ) as a clinical care tool to identify lower extremity lymphedema in gynecologic cancer survivors. Gynecol Oncol. 2010;117(2):317–23. https://doi.org/10.1016/j.ygyno.2010.01.022 .
doi: 10.1016/j.ygyno.2010.01.022 pubmed: 20163847 pmcid: 4847724
Benz T, Lehmann S, Sandor PS, Angst F. Relationship between subjectively-rated and objectively-tested physical function across six different medical diagnoses. J Rehabil Med. 2023. https://doi.org/10.2340/jrm.v55.9383 .
doi: 10.2340/jrm.v55.9383 pubmed: 38050460 pmcid: 10711800
Xu C, Schaverien MV, Christensen JM, Sidey-Gibbons CJ. Efficient and precise ultra-QuickDASH scale measuring lymphedema impact developed using computerized adaptive testing. Qual Life Res. 2022;31(3):917–25. https://doi.org/10.1007/s11136-021-02979-y .
doi: 10.1007/s11136-021-02979-y pubmed: 34590202
Deutscher D, Hayes D, Cook KF, et al. Upper quadrant edema patient-reported outcome measure is reliable, valid, and efficient for patients with lymphatic and venous disorders. Phys Ther. 2021. https://doi.org/10.1093/ptj/pzab219 .
doi: 10.1093/ptj/pzab219 pubmed: 34636891
Deutscher D, Kallen MA, Hayes D, et al. Lower quadrant edema patient-reported outcome measure is reliable, valid, and efficient for patients with lymphatic and venous disorders. Phys Ther. 2023. https://doi.org/10.1093/ptj/pzad083 .
doi: 10.1093/ptj/pzad083 pubmed: 37682087
Xu C, Christensen JM, Haykal T, Asaad M, Sidey-Gibbons C, Schaverien M. Measurement properties of the lymphedema life impact scale. Lymphat Res Biol. 2022;20(4):425–34. https://doi.org/10.1089/lrb.2021.0051 .
doi: 10.1089/lrb.2021.0051 pubmed: 34842442
Greene AK, Slavin SA. What is the best imaging modality to confirm the diagnosis of lymphedema? In: Weinzweig J, editor. Plastic surgery secrets plus. 2nd ed. Amsterdam: Elsevier; 2010. p. 630–5.
doi: 10.1016/B978-0-323-03470-8.00096-X
Weber E, Aglianò M, Bertelli E, Gabriele G, Gennaro P, Barone V. Lymphatic collecting vessels in health and disease: a review of histopathological modifications in lymphedema. Lymphat Res Biol. 2022;20(5):468–77. https://doi.org/10.1089/lrb.2021.0090 .
doi: 10.1089/lrb.2021.0090 pubmed: 35041535 pmcid: 9603277
Committee E. The Diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the international society of lymphology. Lymphology. 2016;49(4):170–84.
Pappalardo M, Cheng MH. Lymphoscintigraphy for the diagnosis of extremity lymphedema: current controversies regarding protocol, interpretation, and clinical application. J Surg Oncol. 2020;121(1):37–47. https://doi.org/10.1002/jso.25526 .
doi: 10.1002/jso.25526 pubmed: 31209893
Pappalardo M, Cheng MH. A new lymphoscintigraphy staging for unilateral extremity lymphedema: validation and correlation between nuclear images and clinical findings. Plast Reconstr Surg Glob Open. 2018;6(9S):74–5.
pmcid: 6212040 doi: 10.1097/01.GOX.0000546918.33068.82
Dylke ES, McEntee MF, Schembri GP, Brennan PC, Bailey E, Ward LC, Kilbreath SL. Reliability of a radiological grading system for dermal backflow in lymphoscintigraphy imaging. Acad Radiol. 2013;20(6):758–63.
pubmed: 23570659 doi: 10.1016/j.acra.2013.01.018
Oh A, Kajita H, Imanishi N, Sakuma H, Takatsume Y, Okabe K, Aiso S, Kishi K. Three-dimensional analysis of dermal backflow in cancer-related lymphedema using photoacoustic lymphangiography. Arch Plast Surg. 2022;49(01):99–107.
pubmed: 35086318 pmcid: 8795642 doi: 10.5999/aps.2021.01235
Villa G, Campisi CC, Ryan M, Boccardo F, Di Summa P, Frascio M, Sambuceti G, Campisi C. Procedural recommendations for lymphoscintigraphy in the diagnosis of peripheral lymphedema: the Genoa protocol. Nucl Med Mol Imaging. 2019;53:47–56.
pubmed: 30828401 pmcid: 6377575 doi: 10.1007/s13139-018-0565-2
Yoon HJ, Woo KJ, Kim JY, Kang SY, Moon BS, Kim BS. The added value of SPECT/CT lymphoscintigraphy in the initial assessment of secondary extremity lymphedema patients. Sci Rep. 2023;13(1):19494. https://doi.org/10.1038/s41598-023-44471-2 .
doi: 10.1038/s41598-023-44471-2 pubmed: 37945581 pmcid: 10636025
Tassenoy A, De Strijcker D, Adriaenssens N, Lievens P. The use of noninvasive imaging techniques in the assessment of secondary lymphedema tissue changes as part of staging lymphedema. Lymphat Res Biol. 2016;14(3):127–33.
pubmed: 27631582 doi: 10.1089/lrb.2016.0011
Ricci V, Ricci C, Gervasoni F, Giulio C, Farì G, Andreoli A, Özçakar L. From physical to ultrasound examination in lymphedema: a novel dynamic approach. J Ultrasound. 2022. https://doi.org/10.1007/s40477-021-00633-4 .
doi: 10.1007/s40477-021-00633-4 pubmed: 35041158 pmcid: 9402824
Iker E, Mayfield CK, Gould DJ, Patel KM. Characterizing lower extremity lymphedema and lipedema with cutaneous ultrasonography and an objective computer-assisted measurement of dermal echogenicity. Lymphat Res Biol. 2019;17(5):525–30.
pubmed: 30615553 doi: 10.1089/lrb.2017.0090
Forte AJ, Huayllani MT, Boczar D, Cinotto G, McLaughlin SA. Ultrasound elastography use in lower extremity lymphedema: a systematic review of the literature. Cureus. 2019. https://doi.org/10.7759/cureus.5578 .
doi: 10.7759/cureus.5578 pubmed: 31886094 pmcid: 6907718
Bianchi A, Visconti G, Hayashi A, Santoro A, Longo V, Salgarello M. Ultra-high frequency ultrasound imaging of lymphatic channels correlates with their histological features: a step forward in lymphatic surgery. J Plast Reconstr Aesthet Surg. 2020;73(9):1622–9.
pubmed: 32591265 doi: 10.1016/j.bjps.2020.05.053
Naouri M, Samimi M, Atlan M, Perrodeau E, Vallin C, Zakine G, Vaillant L, Machet L. High-resolution cutaneous ultrasonography to differentiate lipoedema from lymphoedema. Br J Dermatol. 2010;163(2):296–301.
pubmed: 20408836 doi: 10.1111/j.1365-2133.2010.09810.x
Monnin-Delhom ED, Gallix BP, Archard C, Bruel JM, Janbon C. High resolution unenhanced computed tomography in patients with swollen legs. Lymphology. 2002;35(3):121–8.
pubmed: 12363222
Lee DG, Lee S, Kim KT. Computed tomography-based quantitative analysis of fibrotic changes in skin and subcutaneous tissue in lower extremity lymphedema following gynecologic cancer surgery. Lymphat Res Biol. 2022;20(5):488–95.
pubmed: 35012367
Shin SU, Lee W, Park EA, Shin CI, Chung JW, Park JH. Comparison of characteristic CT findings of lymphedema, cellulitis, and generalized edema in lower leg swelling. Int J Cardiovasc Imaging. 2013;29:135–43.
pubmed: 24293042 doi: 10.1007/s10554-013-0332-5
Yoo JS, Chung SH, Lim MC, Kim YJ, Kim KG, Hwang JH, Kim YH. Computed tomography-based quantitative assessment of lower extremity lymphedema following treatment for gynecologic cancer. J Gynecol Oncol. 2017;28(2):e18. https://doi.org/10.3802/jgo.2017.28.e18 .
doi: 10.3802/jgo.2017.28.e18 pubmed: 28028991
Mihara M, Hara H, Araki J, Kikuchi K, Narushima M, Yamamoto T, Iida T, Yoshimatsu H, Murai N, Mitsui K, Okitsu T, Koshima I. Indocyanine green (ICG) lymphography is superior to lymphoscintigraphy for diagnostic imaging of early lymphedema of the upper limbs. PLoS ONE. 2012;7:e38182. https://doi.org/10.1371/journal.pone.0038182 .
doi: 10.1371/journal.pone.0038182 pubmed: 22675520 pmcid: 3366958
Rasmussen JC, Tan I-C, Marshall MV, Adams KE, Kwon S, Fife CE, Maus EA, Smith LA, Covington KR, Sevick-Muraca EM. Human lymphatic architecture and dynamic transport imaged using near-infrared fluorescence. Transl Oncol. 2010;3:362–72. https://doi.org/10.1593/tlo/10190 .
doi: 10.1593/tlo/10190 pubmed: 21151475 pmcid: 3000461
Zhu B, Rasmussen JC, Sevick-Muraca EM. A matter of collection and detection for intraoperative and noninvasive near-infrared fluorescence molecular imaging: to see or not to see? Med Phy. 2014;41:022105.
doi: 10.1118/1.4862514
Abbaci M, Conversano A, De Leeuw F, Laplace-Builhé C, Mazouni C. Near-infrared fluorescence imaging for the prevention and management of breast cancer-related lymphedema: a systematic review. Eur J Surg Oncol. 2019;45:1778–86. https://doi.org/10.1016/j.ejso.2019.06.009 .
doi: 10.1016/j.ejso.2019.06.009 pubmed: 31221460
Aldrich MB, Rasmussen JC, Fife CE, Shaitelman SF, Sevick-Muraca EM. The development and treatment of lymphatic dysfunction in cancer patients and survivors. Cancers. 2020;12:2280. https://doi.org/10.3390/cancers120822808 .
doi: 10.3390/cancers120822808 pubmed: 32823928 pmcid: 7466081
Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;112(12):2809–19. https://doi.org/10.1002/cncr.23494 .
doi: 10.1002/cncr.23494 pubmed: 18428212
Aldrich MB, Rasmussen JC, DeSnyder SM, Woodward WA, Chan W, Sevick-Muraca EM, Mittendorf EA, Smith DB, Stauder MC, Strom EA, Perkins GH, Hoffman KE, Mitchell MP, Barcenas CH, Isales LE, Shaitelman SF. Prediction of breast cancer-related lymphedema by dermal backflow detected with near-infrared fluorescence lymphatic imaging. Breast Cancer Res Treat. 2022;195:33–41. https://doi.org/10.1007/s10549-022-06667-4 .
doi: 10.1007/s10549-022-06667-4 pubmed: 35816269 pmcid: 9272652
Stolarz AJ, Sarimollaoglu M, Marecki JC, Fletcher TW, Galanzha EI, Rhee SW, Zharov VP, Klimberg VS, Rusch NJ. Doxorubicin activates ryanodine receptors in rat lymphatic muscle cells to attenuate rhythmic contractions and lymph flow. J Pharmacol Exp Ther. 2019;371(2):278–89. https://doi.org/10.1124/jpet.119.257592 .
doi: 10.1124/jpet.119.257592 pubmed: 31439806 pmcid: 6815939
Aldrich MB, Sevick-Muraca EM. Cytokines are systemic effectors of lymphatic function in acute inflammation. Cytokine. 2013;64(1):362–9. https://doi.org/10.1016/j.cyto.2013.05.015 .
doi: 10.1016/j.cyto.2013.05.015 pubmed: 23764549 pmcid: 3771384
Tan I-C, Maus EA, Rasmussen JC, Marshall MV, Adams KE, Fife CE, Smith LA, Chan W, Sevick-Muraca EM. Assessment of lymphatic contractile function following manual lymphatic drainage using near-infrared fluorescence imaging. Arch Phys Med Rehabil. 2011;92:756-764.e1. https://doi.org/10.1016/j.apmr.2010.12.027 .
doi: 10.1016/j.apmr.2010.12.027 pubmed: 21530723 pmcid: 3109491
Adams KE, Rasmussen JC, Darne C, Tan I-C, Aldrich MB, Marshall MV, Fife CE, Maus EA, Smith LA, Guilloid R, Hoy S, Sevick-Muraca EM. Direct evidence of lymphatic function improvement after advanced pneumatic compression device treatment of lymphedema. Biomed Opt Express. 2010;1:114–25.
pubmed: 21258451 pmcid: 3005162 doi: 10.1364/BOE.1.000114
Aldrich MB, Gross D, Morrow JR, Fife CE, Rasmussen JC. Effect of pneumatic compression therapy on lymph movement in lymphedema-affected extremities, as assessed by near-infrared fluorescence lymphatic imaging. J Innov Opt Health Sci. 2017;10:1650049. https://doi.org/10.1142/S1793545816500498 .
doi: 10.1142/S1793545816500498 pubmed: 29104671
Belgrado JP, Vandermeeren L, Vankerckhove S, Valsamis JB, Malloizel-Delaunay J, Moraine JJ, Liebens F. Near-infrared fluorescence lymphatic imaging to reconsider occlusion pressure of superficial lymphatic collectors in upper extremities of healthy volunteers. Lymphat Res Biol. 2016;14:70–7.
pubmed: 27167187 pmcid: 4926199 doi: 10.1089/lrb.2015.0040
Lipman K, Luan A, Stone K, Wapnir I, Karin M, Nguyen D. Lymphatic microsurgical preventive healing approach (LYMPHA) for lymphedema prevention after axillary lymph node dissection—a single institution experience and feasibility of technique. J Clin Med. 2022;11:92.
doi: 10.3390/jcm11010092
Borri M, Gordon KD, Hughes JC, Scurr ED, Koh DM, Leach MO, Mortimer PS, Schmidt MA. Magnetic resonance imaging-based assessment of breast cancer-related lymphoedema tissue composition. Invest Radiol. 2017;52(9):554–61.
pubmed: 28538023 pmcid: 5548500 doi: 10.1097/RLI.0000000000000386
Crescenzi R, Donahue PMC, Garza M, Lee CA, Patel NJ, Gonzalez V, Jones RS, Donahue MJ. Elevated magnetic resonance imaging measures of adipose tissue deposition in women with breast cancer treatment-related lymphedema. Breast Cancer Res Treat. 2022;191(1):115–24.
pubmed: 34687412 doi: 10.1007/s10549-021-06419-w
Mills M, van Zanten M, Borri M, Mortimer PS, Gordon K, Ostergaard P, Howe FA. Systematic review of magnetic resonance lymphangiography from a technical perspective. J Magn Reson Imaging. 2021;53(6):1766–90.
pubmed: 33625795 pmcid: 7611641 doi: 10.1002/jmri.27542
Donahue PMC, Crescenzi R, Petersen KJ, Garza M, Patel N, Lee C, Chen SC, Donahue MJ. Physical therapy in women with early stage lipedema: potential impact of multimodal manual therapy, compression, exercise, and education interventions. Lymphat Res Biol. 2021. https://doi.org/10.1089/lrb.2021.0039 .
doi: 10.1089/lrb.2021.0039 pubmed: 34748408
Crescenzi R, Donahue PMC, Hartley KG, Desai AA, Scott AO, Braxton V, Mahany H, Lants SK, Donahue MJ. Lymphedema evaluation using noninvasive 3T MR lymphangiography. J Magn Reson Imaging. 2017;46(5):1349–60. https://doi.org/10.1002/jmri.25670 .
doi: 10.1002/jmri.25670 pubmed: 28245075 pmcid: 5573666
Salehi BP, Sibley RC, Friedman R, Kim G, Singhal D, Loening AM, Tsai LL. MRI of lymphedema. J Magn Reson Imaging. 2023;57(4):977–91.
pubmed: 36271779 doi: 10.1002/jmri.28496
Rane S, Donahue PMC, Towse T, Ridner S, Chappell M, Jordi J, Gore J, Donahue MJ. Clinical feasibility of noninvasive visualization of lymphatic flow with principles of spin labeling MR imaging: implications for lymphedema assessment. Radiology. 2013;269(3):893–902. https://doi.org/10.1148/radiol.13120145 .
doi: 10.1148/radiol.13120145 pubmed: 23864103
Crescenzi R, Donahue PM, Braxton VG, Scott AO, Mahany HB, Lants SK, Donahue MJ. 3.0 T relaxation time measurements of human lymph nodes in adults with and without lymphatic insufficiency: Implications for magnetic resonance lymphatic imaging. NMR Biomed. 2018;31(12):e4009.
pubmed: 30311705 pmcid: 6263822 doi: 10.1002/nbm.4009
Donahue PM, Crescenzi R, Scott AO, Braxton V, Desai A, Smith SA, Jordi J, Meszoely IM, Grau AM, Kauffmann RM. Bilateral changes in deep tissue environment after manual lymphatic drainage in patients with breast cancer treatment-related lymphedema. Lymphat Res Biol. 2017;15(1):45–56.
pubmed: 28323572 pmcid: 5369395 doi: 10.1089/lrb.2016.0020
Maki JH, Neligan PC, Briller N, Mitsumori LM, Wilson GJ. Dark blood magnetic resonance lymphangiography using dual-agent relaxivity contrast (DARC-MRL): a novel method combining gadolinium and iron contrast agents. Curr Probl Diagn Radiol. 2016;45(3):174–9.
pubmed: 26460054 doi: 10.1067/j.cpradiol.2015.08.003
Crescenzi R, Donahue PMC, Mahany H, Lants SK, Donahue MJ. CEST MRI quantification procedures for breast cancer treatment-related lymphedema therapy evaluation. Magn Reson Med. 2020;83(5):1760–73.
pubmed: 31631410 doi: 10.1002/mrm.28031
Crescenzi R, Donahue PMC, Petersen KJ, Garza M, Patel N, Lee C, Beckman JA, Donahue MJ. Upper and lower extremity measurement of tissue sodium and fat content in patients with lipedema. Obesity (Silver Spring). 2020;28(5):907–15.
pubmed: 32270924 doi: 10.1002/oby.22778
Crescenzi R, Marton A, Donahue PMC, Mahany HB, Lants SK, Wang P, Beckman JA, Donahue MJ, Titze J. Tissue sodium content is elevated in the skin and subcutaneous adipose tissue in women with lipedema. Obesity (Silver Spring). 2018;26(2):310–7.
pubmed: 29280322 doi: 10.1002/oby.22090
Munoz DC, Virk SS, Oladeru OT, et al. Practical approach to establishing a lymphedema screening program: tips and tricks. Curr Breast Cancer Rep. 2023;15(3):242–51. https://doi.org/10.1007/s12609-023-00501-6 .
doi: 10.1007/s12609-023-00501-6
Ward LC, Thompson B, Gaitatzis K, Koelmeyer LA. Comparison of volume measurements and bioimpedance spectroscopy using a stand-on device for assessment of unilateral breast cancer-related lymphedema. Eur J Breast Health. 2024;20(2):141–8. https://doi.org/10.4274/ejbh.galenos.2024.2023-12-8.PMID:38571690;PMCID:PMC10985575 .
doi: 10.4274/ejbh.galenos.2024.2023-12-8.PMID:38571690;PMCID:PMC10985575 pubmed: 38571690 pmcid: 10985575
Qin ES, Bowen MJ, Chen WF. Diagnostic accuracy of bioimpedance spectroscopy in patients with lymphedema: a retrospective cohort analysis. J Plast Reconstr Aesthet Surg. 2018;71(7):1041–50. https://doi.org/10.1016/j.bjps.2018.02.012 .
doi: 10.1016/j.bjps.2018.02.012 pubmed: 29650264
Ridner SH, Dietrich MS, Boyages J, Koelmeyer L, Elder E, Hughes TM, French J, Ngui N, Hsu J, Abramson VG, Moore A. A comparison of bioimpedance spectroscopy or tape measure triggered compression intervention in chronic breast cancer lymphedema prevention. Lymphat Res Biol. 2022;20(6):618–28.
pubmed: 35099283 pmcid: 9810346 doi: 10.1089/lrb.2021.0084
Bundred NJ, Stockton C, Keeley V, Riches K, Ashcroft L, Evans A, Skene A, Purushotham A, Bramley M, Hodgkiss T, Investigators of BEA PLACE studies. Comparison of multi-frequency bioimpedance with perometry for the early detection and intervention of lymphoedema after axillary node clearance for breast cancer. Breast Cancer Res Treat. 2015;151(1):121–9. https://doi.org/10.1007/s10549-015-3357-8 .
doi: 10.1007/s10549-015-3357-8 pubmed: 25850535
Ward LC, Czerniec S, Kilbreath SL. Operational equivalence of bioimpedance indices and perometry for the assessment of unilateral arm lymphedema. Lymphat Res Biol. 2009;7(2):81–5. https://doi.org/10.1089/lrb.2008.1027 .
doi: 10.1089/lrb.2008.1027 pubmed: 19522677
Coroneos CJ, Wong FC, DeSnyder SM, Shaitelman SF, Schaverien MV. Correlation of L-dex bioimpedance spectroscopy with limb volume and lymphatic function in lymphedema. Lymphat Res Biol. 2019;17(3):301–7. https://doi.org/10.1089/lrb.2018.0028 .
doi: 10.1089/lrb.2018.0028 pubmed: 30388062
Czerniec SA, Ward LC, Lee MJ, et al. Segmental measurement of breast cancer-related arm lymphoedema using perometry and bioimpedance spectroscopy. Support Care Cancer. 2011;19:703–10. https://doi.org/10.1007/s00520-010-0896-8 .
doi: 10.1007/s00520-010-0896-8 pubmed: 20467755
Koelmeyer L, Thompson B, Mackie H, Blackwell R, Heydon-White A, Moloney E, Gaitatzis K, Boyages J, Suami H. Personalizing conservative lymphedema management using ICG-guided manual lymphatic drainage. Lymphat Res Biol. 2021;19(1):56–65.
pubmed: 33270517 doi: 10.1089/lrb.2020.0090
Benjamin J, O’Leary C, Hur S, Gurevich A, Klein WM, Itkin M. Imaging and interventions for lymphatic and lymphatic-related disorders. Radiology. 2023;307(3):e220231. https://doi.org/10.1148/radiol.220231 .
doi: 10.1148/radiol.220231 pubmed: 36943078
Moon T, O’Donnell TF, Weycker D, Iafrati M. Lymphoscintigraphy is frequently recommended but seldom used in a “real world setting.” J Vasc Surg Venous Lymphat Disord. 2024;12(2):101738. https://doi.org/10.1016/j.jvsv.2023.101738 .
doi: 10.1016/j.jvsv.2023.101738 pubmed: 38103890
Guermazi A, Brice P, Hennequin C, Sarfati E. Lymphography: an old technique retains its usefulness. Radiographics. 2003;23(6):1541–58. https://doi.org/10.1148/rg.236035704 .
doi: 10.1148/rg.236035704 pubmed: 14615563
Fadhil M, Singh R, Havas T, Jacobson I. Systematic review of head and neck lymphedema assessment. Head Neck. 2022;44(10):2301–15. https://doi.org/10.1002/hed.27136 .
doi: 10.1002/hed.27136 pubmed: 35818729
van Schaik CJ, Boer LL, Draaisma JMT, van der Vleuten CJM, Janssen JJ, Fütterer JJ, Schultze Kool LJ, Klein WM. The lymphatic system throughout history: From hieroglyphic translations to state of the art radiological techniques. Clin Anat. 2022;35(6):701–10. https://doi.org/10.1002/ca.23867 .
doi: 10.1002/ca.23867 pubmed: 35383381 pmcid: 9542037

Auteurs

Mary Vargo (M)

Department of Physical Medicine and Rehabilitation, MetroHealth Rehabilitation Institute, Case Western Reserve University, Cleveland, OH, USA.

Melissa Aldrich (M)

Center for Molecular Imaging, UTHealth, Houston, TX, USA.

Paula Donahue (P)

Department of Physical Medicine and Rehabilitation, Vanderbilt University Medical Center, Nashville, TN, USA.

Emily Iker (E)

Lymphedema Center, Santa Monica, CA, USA.

Louise Koelmeyer (L)

Australian Lymphoedema Education, Research & Treatment (ALERT) Program, Macquarie University, Sydney, Australia. louise.koelmeyer@mq.edu.au.

Rachelle Crescenzi (R)

Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.

Andrea Cheville (A)

Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH